Swedish Heart and Vascular Institute, during which he used the
Stereotaxis system to produce a 3D vascular map and successfully cross
a subclavian stenosis to permit stent deployment. A prior two-hour
conventional percutaneous intervention of this patient was unsuccessful
due to extreme vessel tortuosity and larger vessel diameter. However,
crossing of the subclavian lesion with a Stereotaxis 3D vessel roadmap
and magnetic guidewire tip guidance was accomplished in less than 10
seconds of wiring time.
"The Stereotaxis Magnetic Navigation platform enabled our procedure significantly by facilitating the passage of wires in complex peripheral anatomy," said Dr. Reisman. "This patient benefited by the reduced procedure time and contrast load, and resulted in the minimizing of potential complications to the neurovascular circulation."
"We are very pleased that these three patients were able to receive the treatment they needed, and that all are recovering well," said Bevil Hogg, CEO of Stereotaxis. "Their procedures demonstrate the clinical value of Stereotaxis' 3D vessel roadmaps and distal tip control of magnetic guidewires in the treatment of complex coronary and peripheral vasculature disease. We believe that Stereotaxis' advanced coronary and peripheral navigation capabilities can bring a new level of simplicity, safety and precision to a variety of vascular interventions, and we were proud that leading cardiologists chose to use our technology in live cases at TCT."
At TCT, Stereotaxis showcased the interventional cardiology
capabilities of its Stereotaxis Magnetic Navigation System, which include
CTO vessel road mapping and image integration, as well as the global
connectivity capabilities of its Odyssey(TM) Network Solutions. In the
"Cath Lab of the Future," which was sponsored by TCT, the company
demonstrated important advances in vascular
|SOURCE Stereotaxis, Inc.|
Copyright©2007 PR Newswire.
All rights reserved